Parkway Life REIT 2HFY2024 DPU Dips 1.3% Y-O-Y to 7.38 Cents

The Edge Singapore
02-05

Plife REIT says it is committed to "strengthening" its core presence in Singapore

Parkway Life REIT has reported a distribution per unit of 7.38 cents for its 2HFY2024 ended Dec 31 2024, down 1.3% over the preceding half year. This brings its full-year payout to 14.92 cents, up 1% over FY2023, thereby chalking up 17 straight years of growth in recurring DPU.

If the enlarged unit base due to a recent round of fund-raising from unitholders is excluded, DPU for the whole of FY2024 would be 15.11 cents, up 2.3% over FY2023's 14.77 cents.

In 2HFY2024, the REIT's net property income was down 1.1% y-o-y to $68.2 million, bringing the full-year NPI to $136.6 million, down 1.8% y-o-y.

Gross revenue reached $72.8 million for the second half and $145.3 million for the whole of FY2024.

The REIT now hedges around 87% of its exposure. Its all-in debt cost is 1.48%, 9.8 times interest cover ratio, and has a gearing ratio of 34.8%.

PLife REIT says the recently acquired portfolio of nursing homes in France helps diversify its overall asset base and provide long-term rental income stability.

Going forward, Plife REIT says it is committed to "strengthening" its core presence in Singapore and "consolidating" its position in Japan and Europe.

"We are pleased with the resilience of our portfolio and the continued growth in FY 2024. The acquisition of the French nursing homes is a significant step in enhancing portfolio diversification and improving long-term income growth and stability," says Yong Yean Chau, CEO of the REIT's manager.

"With a disciplined approach to capital management and a globally diversified portfolio, we are confident in our ability to navigate future opportunities and challenges while delivering long-term sustainable value to our unitholders," he adds.

Parkway Life REIT units closed at $3.94 on Feb 5, up 1.55% for the day and up 9.75% in the past 12 months.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10